首页> 外文期刊>Journal of tissue engineering and regenerative medicine >Histatin-1 is a novel osteogenic factor that promotes bone cell adhesion, migration, and differentiation
【24h】

Histatin-1 is a novel osteogenic factor that promotes bone cell adhesion, migration, and differentiation

机译:组织素-1是促进骨细胞粘附,迁移和分化的新型成骨因子

获取原文
获取原文并翻译 | 示例
           

摘要

Histatin-1 is a salivary antimicrobial peptide involved in the maintenance of enamel and oral mucosal homeostasis. Moreover, Histatin-1 has been shown to promote re-epithelialization in soft tissues, by stimulating cell adhesion and migration in oral and dermal keratinocytes, gingival and skin fibroblasts, endothelial cells and corneal epithelial cells. The broad-spectrum activity of Histatin-1 suggests that it behaves as a universal wound healing promoter, although this is far from being clear yet. Here, we report that Histatin-1 is a novel osteogenic factor that promotes bone cell adhesion, migration, and differentiation. Specifically, Histatin-1 promoted cell adhesion, spreading, and migration of SAOS-2 cells and MC3T3-E1 preosteoblasts in vitro, when placed on a fibronectin matrix. Besides, Histatin-1 induced the expression of osteogenic genes, including osteocalcin, osteopontin, and Runx2, and increased both activity and protein levels of alkaline phosphatase. Furthermore, Histatin-1 promoted mineralization in vitro, as it augmented the formation of calcium deposits in both SAOS-2 and MC3T3-E1 cells. Mechanistically, although Histatin-1 failed to activate ERK1/2, FAK, and Akt, which are signaling proteins associated with osteogenic differentiation or cell migration, it triggered nuclear relocalization of beta-catenin. Strikingly, the effects of Histatin-1 were recapitulated in cells that are nonosteogenically committed, since it promoted surface adhesion, migration, and the acquisition of osteogenic markers in primary mesenchymal cells derived from the apical papilla and dental pulp. Collectively, these observations indicate that Histatin-1 is a novel osteogenic factor that promotes bone cell differentiation, surface adhesion and migration, as crucial events required for bone tissue regeneration.
机译:组氨酸蛋白酶抑制剂-1是一种唾液抗菌肽,参与维持牙釉质和口腔粘膜内稳态。此外,组氨酸蛋白酶抑制剂-1通过刺激口腔和真皮角质形成细胞、牙龈和皮肤成纤维细胞、内皮细胞和角膜上皮细胞中的细胞粘附和迁移,促进软组织中的再上皮化。组氨酸蛋白酶抑制剂-1的广谱活性表明它是一种普遍的伤口愈合促进剂,尽管这一点尚不清楚。在这里,我们报道了组氨酸蛋白酶抑制剂-1是一种促进骨细胞粘附、迁移和分化的新型成骨因子。具体而言,当将组织蛋白酶-1置于纤维连接蛋白基质上时,组织蛋白酶-1在体外促进SAOS-2细胞和MC3T3-E1前成骨细胞的粘附、扩散和迁移。此外,组织蛋白酶-1诱导成骨基因的表达,包括骨钙素、骨桥蛋白和Runx2,并增加碱性磷酸酶的活性和蛋白质水平。此外,组氨酸蛋白酶抑制剂-1在体外促进矿化,因为它增加了SAOS-2和MC3T3-E1细胞中钙沉积的形成。在机制上,尽管组织蛋白酶-1未能激活ERK1/2、FAK和Akt,它们是与成骨分化或细胞迁移相关的信号蛋白,但它触发了β-连环蛋白的核再定位。引人注目的是,组氨酸蛋白酶抑制剂-1的作用在非成骨细胞中得到了重现,因为它促进了来自顶端乳头和牙髓的原代间充质细胞的表面粘附、迁移和成骨标记物的获得。总的来说,这些观察结果表明,组织抑素-1是一种新的成骨因子,促进骨细胞分化、表面粘附和迁移,是骨组织再生所需的关键事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号